Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Druckformat: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2018029633
pages 55-59

The Importance of Cancer Stem Cells in Gastrointestinal Cancers

Duygu Altinok Dindar
Health Institute of Turkey, Turkish Cancer Institute, 06434, Ankara, Turkey
Gulsah Albayrak
Department of Medical Biology, Faculty of Medicine, Ufuk University, Balgat, 06520, Ankara, Turkey
Ahmet Ozet
Department of Medical Oncology, Faculty of Medicine, Gazi University, Besevler, 06510, Ankara, Turkey


Cancer is a major cause of death worldwide. Gastrointestinal (GI) cancers are still an important cause of tumor-related deaths. Conventional therapeutic approaches like surgery, chemotherapy, and radiation therapy are indispensable but insufficient. Despite the advances in immunotherapy and other conventional treatment strategies, some might argue that we are still far from curing cancer. Cancer stem cells (CSCs) might be to blame. Because sequencing technologies are moving fast in this precision-medicine era, molecular testing of tumors, circulating tumor cells, and CSCs have important implications for treatment decisions. Biomarkers offer prognostic values and targeted therapy availabilities as molecular predictive factors. CSCs are considered biomarkers of tumorigenesis development, metastasis, and recurrence. In this review, we summarize the important issues over CSCs and the development of new drugs that target GI CSCs.

Articles with similar content:

Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Atul K. Tiwari, Naveen K. Vishvakarma, Dhananjay Shukla, Sapnita Shinde, Saurabh Saxena, Vineeta Dixit
Cancer Stem Cells in Urooncology
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Cag Cal, Zeynep Yuce
Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
Elizabeth Lawlor, Poul H. Sorensen
New Prospectives of Prostate Cancer Gene Therapy: Molecular Targets and Animal Models
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Chia-Ling Hsieh, Leland W. K. Chung
Cancer Stem Cells: Root of the Evil
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Didem Karakas, Merve Erkisa, Engin Ulukaya